2021

1. Heterozygous arrhythmogenic cardiomyopathy-desmoplakin mutation carriers exhibit a subclinical cutaneous phenotype with cell membrane disruption and lack of intercellular adhesion

   Journal of Clinical Medicine, Vol. 10, Núm. 19